Search

everythinglearnresearchcommunity

for

Search:↓

Consider benefits and risks of new alopecia treatments for safety.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Dopamine stops hair growth and pigment production in human scalp hair follicles.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Mesotherapy for hair loss can sometimes cause more hair loss and scarring.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

A woman's rare adrenal tumor caused high testosterone and cortisol levels, which normalized after the tumor was removed.

Antiandrogen therapy helps treat genetic hair loss.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

The boy with woolly hair nevus had thinner hair and abnormal hair follicles, which improved with treatment but worsened when treatment stopped.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

Propylene glycol and ethanol increase finasteride skin absorption, sodium lauryl sulfate doesn't.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Finger length ratio may indicate male hair loss.

The cat had liver cancer and a related hair loss condition, with a likely cause being bile duct cancer.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.